Literature DB >> 1496010

Structure of a human monoclonal antibody Fab fragment against gp41 of human immunodeficiency virus type 1.

X M He1, F Rüker, E Casale, D C Carter.   

Abstract

The three-dimensional structure of a human monoclonal antibody (Fab), which binds specifically to a major epitope of the transmembrane protein gp41 of the human immunodeficiency virus type 1, has been determined by crystallographic methods to a resolution of 2.7 A. It has been previously determined that this antibody recognizes the epitope SGKLICTTAVPWNAS, belongs to the subclass IgG1 (kappa), and exhibits antibody-dependent cellular cytotoxicity. The quaternary structure of the Fab is in an extended conformation with an elbow bend angle between the constant and variable domains of 175 degrees. Structurally, four of the hypervariable loops can be classified according to previously recognized canonical structures. The third hypervariable loops of the heavy (H3) and light chain (L3) are structurally distinct. Hypervariable loop H3, residues 102H-109H, is unusually extended from the surface. The complementarity-determining region forms a hydrophobic binding pocket that is created primarily from hypervariable loops L3, H3, and H2.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1496010      PMCID: PMC49664          DOI: 10.1073/pnas.89.15.7154

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  30 in total

1.  Molecular modeling of antibody combining sites.

Authors:  A C Martin; J C Cheetham; A R Rees
Journal:  Methods Enzymol       Date:  1991       Impact factor: 1.600

2.  Crystallographic R factor refinement by molecular dynamics.

Authors:  A T Brünger; J Kuriyan; M Karplus
Journal:  Science       Date:  1987-01-23       Impact factor: 47.728

3.  Crystal structures of an antibody to a peptide and its complex with peptide antigen at 2.8 A.

Authors:  R L Stanfield; T M Fieser; R A Lerner; I A Wilson
Journal:  Science       Date:  1990-05-11       Impact factor: 47.728

4.  Three-dimensional structure of an antibody-antigen complex.

Authors:  S Sheriff; E W Silverton; E A Padlan; G H Cohen; S J Smith-Gill; B C Finzel; D R Davies
Journal:  Proc Natl Acad Sci U S A       Date:  1987-11       Impact factor: 11.205

5.  Fine mapping of an immunodominant region of the transmembrane protein of the human immunodeficiency virus (HIV-1).

Authors:  S H Döpel; T Porstmann; P Henklein; R von Baehr
Journal:  J Virol Methods       Date:  1989-08       Impact factor: 2.014

6.  Structure of an antibody-antigen complex: crystal structure of the HyHEL-10 Fab-lysozyme complex.

Authors:  E A Padlan; E W Silverton; S Sheriff; G H Cohen; S J Smith-Gill; D R Davies
Journal:  Proc Natl Acad Sci U S A       Date:  1989-08       Impact factor: 11.205

7.  Prediction of the folding of short polypeptide segments by uniform conformational sampling.

Authors:  R E Bruccoleri; M Karplus
Journal:  Biopolymers       Date:  1987-01       Impact factor: 2.505

8.  Generation of an antibody with enhanced affinity and specificity for its antigen by protein engineering.

Authors:  S Roberts; J C Cheetham; A R Rees
Journal:  Nature       Date:  1987 Aug 20-26       Impact factor: 49.962

9.  Protein engineering of antibody binding sites: recovery of specific activity in an anti-digoxin single-chain Fv analogue produced in Escherichia coli.

Authors:  J S Huston; D Levinson; M Mudgett-Hunter; M S Tai; J Novotný; M N Margolies; R J Ridge; R E Bruccoleri; E Haber; R Crea
Journal:  Proc Natl Acad Sci U S A       Date:  1988-08       Impact factor: 11.205

10.  Pilot scale production of a human monoclonal antibody against human immunodeficiency virus HIV-1.

Authors:  A Jungbauer; C Tauer; E Wenisch; F Steindl; M Purtscher; M Reiter; F Unterluggauer; A Buchacher; K Uhl; H Katinger
Journal:  J Biochem Biophys Methods       Date:  1989 Aug-Sep
View more
  12 in total

1.  Somatic mutations of the L12a gene in V-kappa(1) light chain deposition disease: potential effects on aberrant protein conformation and deposition.

Authors:  R Vidal; F Goñi; F Stevens; P Aucouturier; A Kumar; B Frangione; J Ghiso; G Gallo
Journal:  Am J Pathol       Date:  1999-12       Impact factor: 4.307

2.  Structural flexibility and functional valence of CD4-IgG2 (PRO 542): potential for cross-linking human immunodeficiency virus type 1 envelope spikes.

Authors:  P Zhu; W C Olson; K H Roux
Journal:  J Virol       Date:  2001-07       Impact factor: 5.103

3.  Characterization of a quaternary-structured folding intermediate of an antibody Fab-fragment.

Authors:  H Lilie; R Jaenicke; J Buchner
Journal:  Protein Sci       Date:  1995-05       Impact factor: 6.725

4.  Diverse binding site structures revealed in homology models of polyreactive immunoglobulins.

Authors:  P A Ramsland; L W Guddat; A B Edmundson; R L Raison
Journal:  J Comput Aided Mol Des       Date:  1997-09       Impact factor: 3.686

5.  Variable domain-linked oligosaccharides of a human monoclonal IgG: structure and influence on antigen binding.

Authors:  H Leibiger; D Wüstner; R D Stigler; U Marx
Journal:  Biochem J       Date:  1999-03-01       Impact factor: 3.857

6.  Characterization and crystallization of a recombinant IgE Fab fragment in complex with the bovine beta-lactoglobulin allergen.

Authors:  Merja Niemi; Janne Jänis; Sirpa Jylhä; Johanna M Kallio; Nina Hakulinen; Marja-Leena Laukkanen; Kristiina Takkinen; Juha Rouvinen
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2007-12-20

7.  Direct selection for a catalytic mechanism from combinatorial antibody libraries.

Authors:  K D Janda; C H Lo; T Li; C F Barbas; P Wirsching; R A Lerner
Journal:  Proc Natl Acad Sci U S A       Date:  1994-03-29       Impact factor: 11.205

8.  A novel and conserved pocket of human kappa-Fab fragments: design, synthesis, and verification of directed affinity ligands.

Authors:  Enrique Carredano; Herbert Baumann; Anna Grönberg; Nils Norrman; Gunnar Glad; Jinyu Zou; Oguz Ersoy; Elles Steensma; Andreas Axén
Journal:  Protein Sci       Date:  2004-06       Impact factor: 6.725

9.  The structural repertoire of the human V kappa domain.

Authors:  I M Tomlinson; J P Cox; E Gherardi; A M Lesk; C Chothia
Journal:  EMBO J       Date:  1995-09-15       Impact factor: 11.598

10.  Human Non-neutralizing HIV-1 Envelope Monoclonal Antibodies Limit the Number of Founder Viruses during SHIV Mucosal Infection in Rhesus Macaques.

Authors:  Sampa Santra; Georgia D Tomaras; Ranjit Warrier; Nathan I Nicely; Hua-Xin Liao; Justin Pollara; Pinghuang Liu; S Munir Alam; Ruijun Zhang; Sarah L Cocklin; Xiaoying Shen; Ryan Duffy; Shi-Mao Xia; Robert J Schutte; Charles W Pemble Iv; S Moses Dennison; Hui Li; Andrew Chao; Kora Vidnovic; Abbey Evans; Katja Klein; Amit Kumar; James Robinson; Gary Landucci; Donald N Forthal; David C Montefiori; Jaranit Kaewkungwal; Sorachai Nitayaphan; Punnee Pitisuttithum; Supachai Rerks-Ngarm; Merlin L Robb; Nelson L Michael; Jerome H Kim; Kelly A Soderberg; Elena E Giorgi; Lily Blair; Bette T Korber; Christiane Moog; Robin J Shattock; Norman L Letvin; Joern E Schmitz; M A Moody; Feng Gao; Guido Ferrari; George M Shaw; Barton F Haynes
Journal:  PLoS Pathog       Date:  2015-08-03       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.